Status:
RECRUITING
Cross-cultural Adaptation and Validity of the Arabic-translated NEUROPATHY-SPECIFIC QUALITY OF LIFE Questionnaire
Lead Sponsor:
Cairo University
Conditions:
Diabetic Neuropathies
Diabetic Peripheral Neuropathy
Eligibility:
All Genders
18-70 years
Brief Summary
PURPOSE: This study will translate, culturally adapt, validate, and test the reliability of the Neuro Qol Arabic version to be used with diabetic patients in Arabic countries. Background: The Neuropa...
Detailed Description
The Neuropathy- and Foot Ulcer-Specific Quality of Life instrument (Neuro QOL) is used worldwide to assess the QOL of diabetic patients with peripheral neuropathy. There is no Arabic version of NeuroQ...
Eligibility Criteria
Inclusion
- Arabic is their first language The absence of any other neurological diagnosis affecting the sensory and motor system, such as stroke or multiple sclerosis
- Age ranges between 18 and 70 years,
- History of DM diagnosed by a physician and confirmed by either hemoglobin A1c ≥6.5% or the use of hypoglycemic agents.
Exclusion
- A hospital inpatient
- Had pre-existing comorbidities such as cancer, shingles or other neuropathic pain entity that predated diabetes or can mimic or cause a neuropathic pain that is not arising as a result of diabetes.
- Pregnant patients as diabetes may be of gestational type
- Had recently experienced physical trauma that may have contributed to neuropathic pain had trauma or dermatological diseases of the skin as this could affect skin sensitivity (e.g. wounds, psoriasis and eczema).
Key Trial Info
Start Date :
February 13 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 25 2026
Estimated Enrollment :
290 Patients enrolled
Trial Details
Trial ID
NCT06483620
Start Date
February 13 2025
End Date
January 25 2026
Last Update
October 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Physical Therapy, Cairo University
Cairo, Giza Governorate, Egypt, 11432